Yield10 Bioscience, Inc.
YTEN · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $1 | $1 |
| % Growth | -86.7% | -26.7% | -23.2% | – |
| Cost of Goods Sold | $0 | $1 | $1 | $5 |
| Gross Profit | -$0 | -$0 | $0 | -$4 |
| % Margin | -383.3% | -45.8% | 5.9% | -553.3% |
| R&D Expenses | $8 | $8 | $6 | $5 |
| G&A Expenses | $6 | $6 | $6 | $5 |
| SG&A Expenses | $6 | $6 | $6 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $14 | $14 | $12 | $10 |
| Operating Income | -$14 | -$13 | -$12 | -$10 |
| % Margin | -24,028.3% | -2,989.1% | -1,904.2% | -1,202.6% |
| Other Income/Exp. Net | -$0 | $0 | $1 | -$1 |
| Pre-Tax Income | -$14 | -$13 | -$11 | -$10 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$14 | -$14 | -$11 | -$10 |
| % Margin | -24,091.7% | -3,014.7% | -1,796.6% | -1,277.3% |
| EPS | -43.66 | -66.25 | -55.95 | -103.21 |
| % Growth | 34.1% | -18.4% | 45.8% | – |
| EPS Diluted | -43.66 | -66.25 | -55.95 | -103.21 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $1 | $1 | $1 |
| EBITDA | -$14 | -$13 | -$11 | -$9 |
| % Margin | -23,545% | -2,930.7% | -1,868.4% | -1,179.8% |